February 21, 2013 article Open access Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer Cancer DOI: 10.1002/cncr.27995 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 203 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study 2024 The Lancet Oncology article Medicine HER2/EGFR in Cancer Research Open access 52 citations 89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study 2023 Cancers article Medicine Medical Imaging Techniques and Applications Open access 17 citations Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials 2021 International Journal of Cancer article Medicine MRI in cancer diagnosis Open access 12 citations Imaging in Locoregional Management of Breast Cancer 2020 Journal of Clinical Oncology article Medicine Breast Lesions and Carcinomas Open access 21 citations 4 results References 0